Événement sur demande

Managing Cancer-Associated Thrombosis

Date de première diffusion :
le mardi 21 juin 2022

Durée : 1 heure

Agnes Lee, M.D., M. Sc., FRCPC
Marc Carrier, M.D., M. Sc., FRCPC

Manage the transition from dual anti-platelet therapy at 12 months post-index event to long term antithrombotic management
Recognize the myth of the stable CAD patient by demonstrating the rate of recurrent event and mortality over 10 years
Define therapeutic options for two typical patient scenarios: 12 months post-PCI and chronic secondary prevention
Summarize different therapeutic options and targets for secondary prevention

Langue : Anglais